Washington Prime Group Board of Directors Declares Quarterly Dividend
COLUMBUS, Ohio, Nov. 13, 2018 (GLOBE NEWSWIRE) — Washington Prime Group Inc. (NYSE: WPG) today announced that the Company’s Board […]
OncoCyte Reports Third Quarter 2018 Financial Results and Progress in DetermaVu™ Development
Transition to New Diagnostic Testing Platform Complete Prospective R&D Validation Study Results Expected by Late 2018 or Early 2019 Development […]
Franklin Limited Duration Income Trust Announces Sources of Monthly Dividend Distribution
SAN MATEO, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) — The Franklin Limited Duration Income Trust [NYSE:FTF] (CUSIP 35472T101) has declared […]
Marrone Bio Innovations, Inc. Reports Third Quarter 2018 Financial Results
Year-Over-Year Revenues Increase 29% to Third Quarter Record of $5.4 Million; Gross Margins Expand to Record 48.3%; Operating Expenses Decrease […]
Quest Resource Holding Reports Third Quarter 2018 Financial Results
Year-Over-Year Adjusted EBITDA improved 32% for the quarter and 43% year to date THE COLONY, Texas, Nov. 13, 2018 (GLOBE […]
ImmuCell Announces Financial Results for Third Quarter of 2018
PORTLAND, Maine, Nov. 13, 2018 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]
aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update
– Initiation of Proof-of-Concept Study in Patients with Pulmonary Sarcoidosis Planned for Fourth Quarter of 2018 – – Conference Call […]
SurveyMonkey Announces Third Quarter 2018 Financial Results
SAN MATEO, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) — SurveyMonkey Inc. (SurveyMonkey), a leading global survey software company, today announced […]
electroCore, Inc. Announces Third Quarter Financial Results
BASKING RIDGE, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) — electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today […]
EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial […]
